Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Fuji Xerox presents Innovation Re:Mix Forum – Future x Smart to re-imagine the future of work

Published

on

Reading Time: 4 minutes

 

Fuji Xerox Singapore, a leading provider in document and communications solutions, today held its second Innovation Re:Mix Forum Future x Smart 2019, at the Marina Bay Sands Expo and Convention Centre. The event brought together industry leaders and senior executives to share research insights and enterprise implementation best practices in enabling a future ‘smarter’ workplace.

The full-day conference was opened by Ms. Sara Cheng, Chief Executive Officer, Fuji Xerox Singapore which was followed by a fireside chat with Dr. Lynn Wilcox, Chief Technical Officer, Fuji Xerox Palo Alto Laboratory (FXPAL). Together, they brought to life the laboratory’s revolutionary technologies on IoT (Internet of Things), IoH (Internet of Humans), Human-Sensing and AI (Artificial Intelligence) and how they shape future workplace collaborations.

“Fuji Xerox is committed to empowering our customers’ digital journey through the integration of Machine, Human and Digital Intelligences which is reinforced in the Innovation Re:Mix’s Forum. This is a fantastic platform for out-of-the-box thinking and thought-provoking conversation to uncover a smart, competitive edge in a digital economy,” said Ms Sara Cheng.

The Future x Smart edition featured an exciting line-up of business and thought leaders participating in keynote presentations, panel discussions, and interactive workshops categorised into three themes:

1. Making the shift to the next-generation enterprise

On creating a ‘smarter’ workplace, Dr Lynn Wilcox and Ms Sara Cheng kicked off the enterprise segment with insights on how enterprises can leverage on ambient computing, and enterprise AI to drive productivity, and improve collaboration and communications in an increasingly mobile workforce. She also introduced FXPAL’s human-sensing technology. With the ability to track stress, productivity, and pain levels, the technology could power employee-retention programs in Human Resource, and potentially revolutionise how medical diagnoses are conducted in Healthcare.

Mr. Chooake Wongwattanasilpa, Managing Director and Head of User Experience & Design at DBS, underscored the importance of design thinking in pursuing innovative solutions as he shared how DBS applied structured thought frameworks for problem-solving.

Panel discussions led by business leaders further armed participants with case studies and insights on how enterprises can better redesign their digital journeys for a ‘smarter workplace’ that maximises business productivity and cost-efficiency.

A hands-on application session at an Experiential Workshop, hosted by experts from Fuji Xerox Digital Platform Solutions, allowed participants to envision a re-invented workplace by using the ‘smart work innovation’ concept to uncover inefficiencies in business workflows.

Other noteworthy speakers and panelists at the enterprise track included:

  • Dr Lily Kong, President, Lee Kong Chian Chair Professor of Social Sciences, Singapore Management University
  • Mr. Angus Luk, Chief Information Officer, South APAC at L’Oreal
  • Dr Cyrille Schwob, Asia-Pacific Head of Technology, Airbus
  • Mr. Patrick Kok, Managing Director, Group Operations Great Eastern Life
  • Mr. Simon Partridge, Head of Insurance Industry, Fuji Xerox Asia Pacific
  • Mr. Ho Swee Huat, Regional Principal, Digital Platforms, Smart Work Innovation, Fuji Xerox Asia Pacific
  • Mr. Daniel Ling, Head of Design Thinking, NTUC Income

2. Revitalising business strategies

The SMB (Small and Medium Business) track offered an exclusive peek at critical factors required to build digital-ready SMBs, along with key highlights on how businesses can edge up in competitiveness in an increasingly connected environment.

Mr. Matthew Teo, Executive Manager, Open Innovation Platform, Infocomm Media Development Authority elaborated on how SMBs can tap on available government programmes and grants to help accelerate their digital journeys. During interactive panel sessions, business leaders offered their first-hand experiences in revitalising businesses with digital solutions, embracing new technologies and enriching the workplace.

Other key speakers and panelists were:

  • Mr. Ryan Chioh, Managing Director, FarEastFlora.com
  • Ms. Supriya Singh, Venture Capitalist, Jafco Asia
  • Mr. Frank Phuan, Chief Executive Officer, Executive Director of Sunseap
  • Mr. K Lingam, Head, Services Offering Development, Fuji Xerox Asia Pacific
  • Mr. Abdul Malik, General Manager and Head of Business Development, Oon & Bazul
  • Mr. Alex Chua, Chief Executive Officer, Goldbell Financial Services
  • Mr. Eugene Yeo, Chief Operating Officer, MyRepublic
  • Mr. Ong Wei Ping, Director, Channel Sales and Alliances, Fuji Xerox Singapore

3. Powering omni-channel marketing strategies

Approaching marketing through multiple platforms is increasingly emphasised against the backdrop of a diverse and fragmented media landscape. With the sheer volume of content transmitted through ever-broadening distribution channels, marketers face the challenge of standing out amid digital clutter.

Ms Susie Wong, Chief Digital & Marketing Officer, Fuji Xerox Singapore, opened the segment with her perspective on tackling the issues of digital fatigue and how brands can leverage on print in omni-channel marketing strategies and trends to differentiate themselves from the next run-off-the-mill digital campaign.

Through a series of workshops and discussions, marketing experts presented solutions for delivering impactful customer experiences, as well as prudently capitalising on print and digital solutions as complements of each other. Creating effective marketing campaigns, tapping on new analytics tools, and learning from successful marketing campaigns were just a few of the topics covered in this conference track.

This conference track featured discussions and workshops led by:

  • Mr. Geoff Tan Managing Director, Market Development, SPH Magazines
  • Mr. Tim Webb, Managing Director, Sequebb
  • Mr. Ben Goodman, Managing Director & Head of DX APAC, Adobe
  • Mr. Tim Howard, Associate Director, Graphic Communications Services Marketing, Fuji Xerox Singapore
  • Ms. Rezwana Manhur, Regional Editor of Singapore and Southeast Asia, Marketing Interactive
  • Mr. Enda Kavanagh, Business Development Manager, XMPie
  • Ms. Ayelet Melamed, Head of Marketing, XMPie

Beyond discussions on new trends and opportunities, and exchanges of innovative ideas, delegates were also taken through Fuji Xerox’s augmented-reality paper trail. Set to redefine traditional processes, the experiential showcase delved into the mechanics of workflow automation and how the technology can be seamlessly applied to any function of a business, offering delegates a first look into redesigning workflows.

The conference concluded on a luxurious note at the “Digital Solutions Meet Gem Wonderland”. Themed “A Cut Above The Rest”, the immersive and creative exhibit featured a radical holographic backdrop and 3-D paper gemstone jewellery specially printed with Fuji Xerox’s Iridesse™ Production Press, PrimeLink™ and B9 Series. Delegates navigated through the endless combinations of paper spectacularly reborn in many unique forms and took away their very own customized tea blend, packaged in a brilliantly cut diamond, exclusively printed by the Iridesse™.

“Digital Solutions Meet Gem Wonderland” demonstrated how print can be reimagined in striking, new ways while it underscored the integration of Machine, Digital and Human intelligence, encapsulating Fuji Xerox’s core value propositions in digital transformation as well. With the multi-faceted capabilities offered by today’s print technology, made possible by cutting-edge research and facilitated by accurate, high-powered digital processing, this exhibit was a study in pushing the boundaries of print in order to offer irreplaceable, infinite value in a digital world.

 

SOURCE Fuji Xerox Singapore

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending